Purchase Order 75N92025P00381
- Not listed
- This federal contract award to Pacific Biosciences of California, Inc. is for the procurement of PacBio Revio Sequencer Systems by the National Human Genome Research Institute (NHGRI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $540,088.00 and is a firm fixed-price purchase order with an ultimate completion date of August 12, 2024. The award was made on June 26, 2024, and there was no set-aside designation used. Pacific Biosciences is a...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Pacific Biosciences of California, Inc. for the delivery of REVIO SPRQ REAGENT KIT. The contract has a ceiling value of $137,088.00 and a period of performance through February 28, 2025. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This is a $85,000.00 firm-fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI) to Pacific Biosciences of California, Inc. for a service contract to provide the Pacific Biosciences Revio, a new sequencing system. The contract has an ultimate completion date of July 31, 2026. Pacific Biosciences is a for-profit biotechnology company that specializes in advanced DNA and RNA sequencing technologies. This contract is not a set-aside. Pacific...
- This firm fixed price purchase order for $19,980.00 was awarded by the National Human Genome Research Institute, a civilian federal agency, to Pacific Biosciences of California, Inc. on December 2, 2020. The award is for the delivery of SMRT CELL 8M TRAYS, with a completion date of January 1, 2021. The contract does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing systems. The company has been awarded over...
- This federal contract award was made by the National Human Genome Research Institute, a civilian agency, to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The $84,000 firm-fixed price purchase order is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and support services. Pacific Biosciences has established itself as a key supplier of specialized long-read sequencing solutions to...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. to provide SEQUEL II SEQUENCING KIT 2.0 BUNDLE. The contract has a potential value of $118,381.00 and a completion date of December 31, 2022. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The company has...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
The National Human Genome Research Institute (NHGRI) has awarded a $198,082.98 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio Single Molecule Real-Time (SMRT) cells and sequencing reagents. This new award, announced on September 16, 2025, with an ultimate completion date of September 26, 2026, represents a direct procurement of specialized laboratory consumables essential for advanced genomic sequencing operations. The contract carries no set-aside designation, indicating it was awarded through full and open competition. Pacific Biosciences will perform the work from its facility in Menlo Park, California, delivering high-throughput, long-read sequencing materials that support the NHGRI's genomic research mission within the National Institutes of Health. Pacific Biosciences is a established federal contractor with extensive experience supplying sequencing technologies and consumables to multiple government agencies, including the USDA, FDA, CDC, and DOD. The company's Revio platform represents its advanced sequencing technology designed to generate high-quality, long-read DNA and RNA sequence data with exceptional accuracy. This award aligns with the company's existing procurement relationships and leverages its specialized expertise in genomic sequencing solutions. The transaction reflects the NHGRI's ongoing need for cutting-edge sequencing materials to support its core mission of advancing human genomic research and understanding genetic contributions to health and disease.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Revio SMRT Cells and Sequencing Reagents | 75N92025Q00129 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 8/25/25, 1:29 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $198.1k | 9/16/25 |